Series C - BAROnova

Series C - BAROnova

Investment Firm

Overview

BAROnova is a clinical-stage medical-device company focused on developing non-surgical non-pharmacologic devices to induce weight loss.

Announced Date

Feb 15, 2013

Funding Type

Series C

Highlights

Location

United States, North America

Social

Investor Lead

Sante Ventures

Sante Ventures

Sante Ventures is a early_stage_venture and late_stage_venture and post_ipo and seed firm.

Boston Scientific

Boston Scientific

No designation

Participant Investors

5

Investor Name
Participant InvestorBoston Scientific
Participant InvestorSante Ventures
Participant InvestorArboretum Ventures
Participant InvestorHighland Capital Partners
Participant InvestorONSET Ventures

Round Details and Background

BAROnova raised $27300000 on 2013-02-15 in Series C

BAROnova is a clinical-stage medical-device company focused on developing non-surgical non-pharmacologic devices to induce weight loss.

Company Funding History

7

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Nov 23, 2015
Series D - BAROnova
5-36.5M
Oct 23, 2008
Series B - BAROnova
4-7.5M
Feb 15, 2013
Series C - BAROnova
6-27.3M
Jan 01, 2006
Series A - BAROnova
3-6.5M

Recent Activity

There is no recent news or activity for this profile.